Cymal-6

• Description :

  Cymal-6 (Cyclohexyl-hexyl-β-D-maltoside) is a potent TEM-1 beta-lactamase inhibitor with an Ki value of 40.05 µM. Cymal-6 (Cyclohexyl-hexyl-β-D-maltoside) can be used as glycosidic surfactant[1][2].

• Product Name Alternative :

  Cyclohexyl-hexyl-β-D-maltoside

• UNSPSC :

  12352005

• Target :

  Bacterial

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/cymal-6.html

• Concentration :

  10mM

• Purity :

  99.67

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  OC[C@@H](O[C@H]([C@@H]([C@H]1O)O)OCCCCCCC2CCCCC2)[C@H]1O[C@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO

• Molecular Formula :

  C24H44O11

• Molecular Weight :

  508.60

• References & Citations :

  [1]Avci FG, et al. Targeting a hidden site on class A beta-lactamases. J Mol Graph Model. 2018 Sep;84:125-133. |[2]Ju M, et al. Enantioseparations by capillary electrophoresis using chiral glycosidic surfactants. II. Comparisonof chiral cyclohexyl-alkyl-β-D-maltoside surfactant. Journal of Liquid Chromatography & Related Technologies. 2000, 23 (1) :35-45.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, protect from light, stored under nitrogen)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [228579-27-9]